JP2022517866A5 - - Google Patents
Info
- Publication number
- JP2022517866A5 JP2022517866A5 JP2021543533A JP2021543533A JP2022517866A5 JP 2022517866 A5 JP2022517866 A5 JP 2022517866A5 JP 2021543533 A JP2021543533 A JP 2021543533A JP 2021543533 A JP2021543533 A JP 2021543533A JP 2022517866 A5 JP2022517866 A5 JP 2022517866A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024161770A JP2024175091A (ja) | 2019-01-29 | 2024-09-19 | Ａｋｔ阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910084801.3 | 2019-01-29 | ||
| CN201910084801 | 2019-01-29 | ||
| PCT/CN2020/073798 WO2020156437A1 (zh) | 2019-01-29 | 2020-01-22 | Akt抑制剂 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024161770A Division JP2024175091A (ja) | 2019-01-29 | 2024-09-19 | Ａｋｔ阻害剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022517866A JP2022517866A (ja) | 2022-03-10 |
| JPWO2020156437A5 JPWO2020156437A5 (https=) | 2023-02-01 |
| JP2022517866A5 true JP2022517866A5 (https=) | 2023-02-01 |
| JP7617005B2 JP7617005B2 (ja) | 2025-01-17 |
Family
ID=71841634
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543533A Active JP7617005B2 (ja) | 2019-01-29 | 2020-01-22 | Ａｋｔ阻害剤 |
| JP2024161770A Withdrawn JP2024175091A (ja) | 2019-01-29 | 2024-09-19 | Ａｋｔ阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024161770A Withdrawn JP2024175091A (ja) | 2019-01-29 | 2024-09-19 | Ａｋｔ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220144821A1 (https=) |
| EP (1) | EP3919491B1 (https=) |
| JP (2) | JP7617005B2 (https=) |
| KR (1) | KR102892239B1 (https=) |
| CN (2) | CN117964620A (https=) |
| AU (1) | AU2020214258B2 (https=) |
| CA (1) | CA3127884A1 (https=) |
| ES (1) | ES3037595T3 (https=) |
| PL (1) | PL3919491T3 (https=) |
| WO (1) | WO2020156437A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI908780B (zh) * | 2020-03-17 | 2025-12-21 | 大陸商江蘇恆瑞醫藥股份有限公司 | 稠合二環類衍生物、其製備方法及其在醫藥上的應用 |
| CN115485276B (zh) * | 2020-05-15 | 2024-05-31 | 南京正大天晴制药有限公司 | 氘代akt激酶抑制剂 |
| CN119302960A (zh) * | 2020-07-22 | 2025-01-14 | 南京正大天晴制药有限公司 | Akt抑制剂的单位剂量组合物 |
| WO2022017448A1 (zh) * | 2020-07-22 | 2022-01-27 | 南京正大天晴制药有限公司 | 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐及晶型 |
| CN115836069B (zh) * | 2020-07-22 | 2024-02-06 | 南京正大天晴制药有限公司 | 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐、其制备方法及用途 |
| CN116478156A (zh) * | 2022-01-17 | 2023-07-25 | 南京正大天晴制药有限公司 | 一种akt抑制剂化合物的富马酸盐晶型及其制备方法 |
| WO2024146599A1 (zh) * | 2023-01-06 | 2024-07-11 | 南京正大天晴制药有限公司 | 一种二氢吡啶并[2,3-d]嘧啶酮的衍生物、其制备方法以及医药用途 |
| CN121586576A (zh) | 2023-06-14 | 2026-02-27 | 南京正大天晴制药有限公司 | Akt抑制剂在制备预防或治疗乳腺癌药物中的用途 |
| CN120157686A (zh) * | 2023-12-14 | 2025-06-17 | 南京正大天晴制药有限公司 | 一种具有降解akt激酶活性的化合物及其制备方法和药学上的应用 |
| CN121177294B (zh) * | 2025-11-27 | 2026-02-27 | 四川省医学科学院·四川省人民医院 | Akt抑制剂在制备诱导胰岛移植免疫耐受药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2546754A1 (en) * | 2003-11-21 | 2005-06-09 | Array Biopharma Inc. | Akt protein kinase inhibitors |
| US20130065908A1 (en) * | 2009-12-07 | 2013-03-14 | Array Biopharma Inc. | Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| UA95641C2 (xx) | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы |
| US8329701B2 (en) | 2006-07-06 | 2012-12-11 | Array Biopharma Inc. | Dihydrofuro pyrimidines as AKT protein kinase inhibitors |
| EP2049500B1 (en) | 2006-07-06 | 2011-09-07 | Array Biopharma, Inc. | Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| CA2711782C (en) | 2008-01-09 | 2017-01-03 | Array Biopharma Inc. | 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| MX2012004780A (es) * | 2009-10-23 | 2012-08-23 | Lilly Co Eli | Inhibidores de akt. |
| CA2890288A1 (en) * | 2012-11-16 | 2014-05-22 | Merck Patent Gmbh | Novel heterocyclic derivatives as modulators of kinase activity |
| AR093511A1 (es) * | 2012-11-16 | 2015-06-10 | Merck Patent Gmbh | Derivados de imidazol-piperidinilo como moduladores de la actividad de cinasas |
| EP3189036B1 (en) * | 2014-09-05 | 2023-07-19 | ArQule, Inc. | Compositions and methods for treating proliferation disorders |
| CN109020957B (zh) * | 2017-06-12 | 2023-01-13 | 南京天印健华医药科技有限公司 | 作为mnk抑制剂的杂环化合物 |
| CN108503645A (zh) * | 2018-03-01 | 2018-09-07 | 山东大学 | 含氨甲基的哌嗪酮类化合物及其制备方法和应用 |
| ES2969982T3 (es) * | 2018-04-24 | 2024-05-23 | Vertex Pharma | Compuestos de pteridinona y usos de los mismos |
-
2020
- 2020-01-22 PL PL20748221.7T patent/PL3919491T3/pl unknown
- 2020-01-22 EP EP20748221.7A patent/EP3919491B1/en active Active
- 2020-01-22 CN CN202410142331.2A patent/CN117964620A/zh active Pending
- 2020-01-22 US US17/426,047 patent/US20220144821A1/en active Pending
- 2020-01-22 JP JP2021543533A patent/JP7617005B2/ja active Active
- 2020-01-22 CA CA3127884A patent/CA3127884A1/en active Pending
- 2020-01-22 WO PCT/CN2020/073798 patent/WO2020156437A1/zh not_active Ceased
- 2020-01-22 KR KR1020217027161A patent/KR102892239B1/ko active Active
- 2020-01-22 AU AU2020214258A patent/AU2020214258B2/en active Active
- 2020-01-22 CN CN202080005749.9A patent/CN113272304B/zh active Active
- 2020-01-22 ES ES20748221T patent/ES3037595T3/es active Active
-
2024
- 2024-09-19 JP JP2024161770A patent/JP2024175091A/ja not_active Withdrawn